Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Bioxis Pharmaceuticals logo — #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine...

Bioxis Pharmaceuticals

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine

Founded 2010 France France 28 employees Series Unknown Total: $2.50M Biotechnology, Medical Devices +1

General Information

Company Name Bioxis Pharmaceuticals
Founded Year 2010
Location France France +1
Employees 28
Industries Biotechnology, Medical Devices, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Bioxis Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bioxis Pharmaceuticals

Bioxis Pharmaceuticals, a France-based company founded in 2010, is making strides in the biotechnology, medical devices, and pharmaceutical industries. Specializing in regenerative medicine, the company aims to transform scientific innovations into medical devices that enhance patient care in dermatology and aesthetic medicine.

The company's innovation prowess is encapsulated in its leading product CYTOSIAL, a dermal filler symbolizing its commitment to surpassing traditional boundaries—as heralded by its slogans: #BeyondInnovation and #DermalFiller. Aimed at fulfilling doctors' needs, Bioxis Pharmaceuticals is strategically positioned in an evolving market with substantial growth potential.

Previous capital infusion includes a substantial €2.50M venture round on 23 September 2016 from investor Juvamed. The last round highlights investor confidence and the company's potential for scalable innovation.

Taxonomy: Regenerative Medicine, Medical Device Development, Dermatology, Aesthetic Medicine, Cosmetic Surgery, Innovation in Medicine, Clinical Development, Product Commercialization, ISO 13485 Certification, Ultra-pure Chitosan, Hyaluronic Acid, Pharmaceutical Industry, Healthcare Innovation, Life Sciences Support, Paris Region Life Sciences Cluster

Services & Products

Discovery of Regenerative Products
Development and Production of Medical Devices
Commercialization of Aesthetic and Dermatological Solutions

Target Customers

Doctors Dermatologists Medical Aesthetic Professionals

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €2.50M 1 Juvamed 23 Sep 2016
Convertible Note Unknown 1
Waarde Capital
01 Apr 2014
Convertible Note Unknown 1
Waarde Capital
01 Jan 2013
Private Equity Round Unknown 1
Waarde Capital
01 Aug 2012

Bioxis Pharmaceuticals Alternatives & Competitors

Bioxis Pharmaceuticals vs
Innovative Medicine, LLC
Innovative Medicine, LLC United States

A world-renowned medical clinic healing body, mind, and spirit.

7 employees
Health Care, Health and Wellness
Bioxis Pharmaceuticals vs
TriCell Biologics
TriCell Biologics India

We are a versatile medical device company and pioneers in bringing life changing regenerative tools...

20 employees
Biotechnology, Medical Devices
Compare Bioxis Pharmaceuticals vs TriCell Biologics
Bioxis Pharmaceuticals vs
RevMedx
RevMedx United States

Saving lives is our mission.

10 employees
Health Care, Medical Devices
Also compare with: Bioxis Pharmaceuticals vs Sperry Bio Sperry Bio Bioxis Pharmaceuticals vs Inavya Ventures Ltd. Inavya Ventures Ltd.

FAQ About Bioxis Pharmaceuticals

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine
Bioxis Pharmaceuticals was founded in 2010.
Bioxis Pharmaceuticals is headquartered in France.
Bioxis Pharmaceuticals operates in the following industries: Biotechnology, Medical Devices, Pharmaceutical.
Bioxis Pharmaceuticals has approximately 28 employees.
Bioxis Pharmaceuticals has completed 4 funding rounds, raising a total of $2.50M. The latest funding stage is Series Unknown.
Bioxis Pharmaceuticals offers: Discovery of Regenerative Products, Development and Production of Medical Devices, Commercialization of Aesthetic and Dermatological Solutions.
Top alternatives and competitors to Bioxis Pharmaceuticals include Innovative Medicine, LLC, TriCell Biologics, RevMedx, Sperry Bio, Inavya Ventures Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioxis Pharmaceuticals and Innovative Medicine, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bioxis Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy